Skip to content

A randomized control study to evaluate the of effect of infiltration of a long acting local anesthetic like bupivacaine, on post operative pain outcome in patients undergoing tonsillectomy .

Evaluation of effect of pre incisional infiltration of bupivacaine on post operative pain outcome in patients undergoing tonsillectomy : a randomized control study - NIL

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058194
Enrollment
64
Registered
2023-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J039- Acute tonsillitis, unspecified Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: bupivacaine: Patients will be randomly divided into two groups: Group A: : In this group the patients (32) will receive 0.5% bupivacaine hydrochloride , in dose of 2mg/kg body weight

Sponsors

Shubham bhatnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children between 5-14 years of age scheduled to undergo tonsillectomy for chronic tonsillitis .

Exclusion criteria

Exclusion criteria: 1.Patients whose parents/guardians are not giving consent for participating in the study. 2. Patients unfit for surgery . 3. Patients having hypersenstivity to bupivacaine .

Design outcomes

Primary

MeasureTime frame
pain outcomeTimepoint: post operative pain outcome on post operative day 0 , 1 , 3 and 5

Secondary

MeasureTime frame
1)Tonsillar fossa healing score 2)Mean time of return to normal diet (in days) , Post op intake(duration, input) 3)Post tonsillectomy requirement of analgesic(I.V Paracetamol) Timepoint: 18 months

Countries

India

Contacts

Public ContactShubham Bhatnagar

Pandit Bhagwat Dayal Sharma University of Health Sciences

naveensharma1380@gmail.com8699596591

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026